前复星医药研发中心高级副总裁吴诸丽加入宜明昂科,任首席医学官

时代财经
10 Jun

本文来源:时代财经6月10日,时代财经获悉,宜明昂科(01541.HK)任命吴诸丽医生为公司首席医学官(CMO),将全面负责公司临床团队的搭建与管理、临床试验研究,以及临床开发与注册工作,向董事长、首席执行官兼首席科学官田文志博士汇报。吴诸丽在血液学、肿瘤学和免疫学的新药临床开发领域拥有超过13年的丰富经验。在加入宜明昂科之前,其曾在包括杨森制药、罗氏和复星医药在内的知名制药公司工作。2018年至...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10